Results 291 to 300 of about 192,885 (309)

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

New England Journal of Medicine, 2021
Aditya Bardia, Sara A Hurvitz, Sara M Tolaney   +2 more
exaly  

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer

New England Journal of Medicine, 2022
Javier Cortes, Lajos Pusztai, Sherko Kümmel   +2 more
exaly  

Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer

Progress in Materials Science, 2023
Xiangyi Kong, Yihang Qi, Yi Fang
exaly  

Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer

Cell, 2021
Fade Gong, Nicholas J Neill, Ik Sun Kim
exaly  

Pembrolizumab for Early Triple-Negative Breast Cancer

New England Journal of Medicine, 2020
Javier Cortes, Lajos Pusztai, Sherko Kümmel   +2 more
exaly  

Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer

New England Journal of Medicine, 2022
Javier Cortes, JOSÉ Pérez-García, Zifang Guo   +2 more
exaly  

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy

Cell Metabolism, 2023
exaly  

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Nature Reviews Clinical Oncology, 2016
Giampaolo Bianchini, Justin M Balko, Íngrid A Mayer   +2 more
exaly  

Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing

Cell, 2018
Charissa Kim, Ruli Gao, Johan Hartman
exaly  

Chemoimmunotherapy for Triple-Negative Breast Cancer

JAMA, 2018
openaire   +2 more sources